Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMFA04010523 4-F3t-NeuroP (4S,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-undeca-2,5,8-dien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 380.26 C22H36O5
LMFA04010008 4-F4-NeuroP (E)-6-(3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010023 4-F4c-NeuroP (S,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010026 4-F4t-NeuroP (S,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010463 4-J4-NeuroP (S,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010425 4-epi-11-A4-NeuroP 3-((1S,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010201 4-epi-11-D4c-NeuroP 3-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010200 4-epi-11-D4t-NeuroP 3-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010329 4-epi-11-E4c-NeuroP 3-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010328 4-epi-11-E4t-NeuroP 3-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010073 4-epi-11-F4c-NeuroP 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010072 4-epi-11-F4t-NeuroP 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010489 4-epi-11-J4-NeuroP 3-((1R,5S)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010395 4-epi-4-A4-NeuroP (R,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010143 4-epi-4-D4c-NeuroP (R,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010146 4-epi-4-D4t-NeuroP (R,E)-4-hydroxy-6-((1S,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010271 4-epi-4-E4c-NeuroP (R,E)-4-hydroxy-6-((1R,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010274 4-epi-4-E4t-NeuroP (R,E)-4-hydroxy-6-((1S,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010015 4-epi-4-F4c-NeuroP (R,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010018 4-epi-4-F4t-NeuroP (R,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010459 4-epi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010525 4-epi-F3t-NeuroP (4R,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-undeca-2,5,8-dien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 380.26 C22H36O5
LMFA04010405 7,10-diepi-7-A4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010161 7,10-diepi-7-D4c-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010160 7,10-diepi-7-D4t-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010289 7,10-diepi-7-E4c-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010288 7,10-diepi-7-E4t-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010033 7,10-diepi-7-F4c-NeuroP (R,4Z,8E)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010032 7,10-diepi-7-F4t-NeuroP (R,4Z,8E)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010469 7,10-diepi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010437 7,14-diepi-14-A4-NeuroP (Z)-6-((1S,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010229 7,14-diepi-14-D4c-NeuroP (Z)-6-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010228 7,14-diepi-14-D4t-NeuroP (Z)-6-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010357 7,14-diepi-14-E4c-NeuroP (Z)-6-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010356 7,14-diepi-14-E4t-NeuroP (Z)-6-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010101 7,14-diepi-14-F4c-NeuroP (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010100 7,14-diepi-14-F4t-NeuroP (Z)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010501 7,14-diepi-14-J4-NeuroP (Z)-6-((1R,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010407 7-A4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010167 7-D4c-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2S,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010170 7-D4t-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010295 7-E4c-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2S,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010298 7-E4t-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R,3R)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010007 7-F4-NeuroP (4Z,8E)-9-(3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010039 7-F4c-NeuroP (S,4Z,8E)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010042 7-F4t-NeuroP (S,4Z,8E)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010471 7-J4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010441 7-epi-14-A4-NeuroP (Z)-6-((1S,2R)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010233 7-epi-14-D4c-NeuroP (Z)-6-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010232 7-epi-14-D4t-NeuroP (Z)-6-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5